A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants.
Qin S, Huang H, Xiao W, Chen K, He X, Tang X, Huang Z, Zhang Y, Duan X, Fan N, Zheng Q, Wu M, Lu G, Wei Y, Wei X, Song X.
Qin S, et al. Among authors: zhang y.
Acta Pharm Sin B. 2023 Jan 12;13(10):4291-304. doi: 10.1016/j.apsb.2023.01.010. Online ahead of print.
Acta Pharm Sin B. 2023.
PMID: 36647424
Free PMC article.